Catawba Research is pleased to announce another achievement for a recently completed rosacea clinical trial. In this trial, Catawba enrolled more than 1000 rosacea subjects in 22 weeks from 33 sites.
The time line for the entire project including investigational product at the site to delivery of final clinical study report was 9 months. Catawba Research continues its excellent 100% track record in successfully completing clinical trials on time without a single change order.
Catawba Research is proud of yet another rapid study completion and committed to achieving aggressive timelines for our clients.
See more about this program in the enclosed press release:
Learn more about our rosacea CRO services or get in touch with us for additional information.
